Currently Viewing:
Newsroom
Currently Reading
Pfizer Announces Phase 3 Trial for Atopic Dermatitis Treatment
December 15, 2017 – Samantha DiGrande
Majority of Women With Breast Cancer Surgery Did Not Feel Fully Informed of Treatment Options
December 15, 2017 – Jaime Rosenberg
AJMC® in the Press, December 15, 2017
December 15, 2017 – AJMC Staff
What We're Reading: Medicare Lab Testing; CHIP Deadline; AMA Expands Diabetes Efforts
December 15, 2017 – AJMC Staff
5 Key Takeaways From ASH 2017
December 15, 2017 – Surabhi Dangi-Garimella, PhD
This Week in Managed Care: December 15, 2017
December 15, 2017
What We're Reading: Medical Device Tax; Marijuana and Vaping; Birth Control Without Prescriptions
December 14, 2017 – AJMC Staff
Study Finds Breathing Retraining Associated With Quality of Life Improvement for Patients With Asthma
December 14, 2017 – Laura Joszt
Rain and Pain Not Related, Harvard Researchers Say
December 13, 2017 – Allison Inserro

Chronic Prostate Inflammation May Increase Prostate Cancer Risk

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer, according to researchers.

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer, according to researchers.

However, Dr. Elizabeth A. Platz told Reuters Health by email, "We don't anticipate direct clinical implications of our work. The prevalence of inflammation in the prostate was so high -- even in the controls (comparison men without a diagnosis of cancer) -- that the mere presence of inflammation could not be used as a tool to identify men at risk for this cancer."

"We performed the work to learn more about the etiology of prostate cancer, especially aggressive disease," added Dr. Platz, of Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

As reported April 18th online in Cancer Epidemiology Biomarkers & Prevention, Dr. Platz and colleagues conducted a case-control study nested in the placebo arm of a large cancer prevention trial. At enrollment, the men were at least 55 years old and had a normal digital rectal examination and a serum prostate-specific antigen (PSA) level of 3 ng/mL or less.

Read the complete stoy here: http://bit.ly/1mF25P9

Source: Medscape

 

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!